Research from UAB published in the New England Journal of Medicine in February 2022 suggests a gene therapy called LentiGlobin could provide a drastic improvement in quality of life for people with ...
Last month, co-directors of the UAB Lifespan Comprehensive Sickle Cell Center Julie Kanter, M.D., (Associate Professor, Hematology and Oncology) and Jeffrey Lebensburger, D.O., (Professor, Pediatric ...
Hosted on MSN11mon
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggleSickle cell has forced him to leave his job and ... Goodwin's hesitancy to pursue treatment is no surprise to Dr. Julie Kanter, director of the Adult Sickle Clinic at the University of Alabama ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback